October 31, 2023

FDA’s “Labeling for Biosimilar and Interchangeable Biosimilar Products; Draft Guidance for Industry: Availability“

Introduction: FDA Draft Guidance “Labeling for Biosimilar and Interchangeable Biosimilar Products”